Quince Therapeutics Revenue, Growth & Competitor Profile

DBA CORTEXYME, INC.

Company Profile & Annual Report for Quince Therapeutics

Access the complete profile.

Quince Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5416 Management, Scientific & Technical Consulting Services
Address	601 Gateway Blvd Ste 1250 South San Francisco, CA 94080

Note: Revenues for privately held companies are statistical evaluations.


Quince Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Quince Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Quince Therapeutics is classified as operating in the Management, Scientific & Technical Consulting Services industry, NAICS Code 5416.

Quince Therapeutics Annual Revenue and Growth Rate

Quince Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Quince Therapeutics's revenues are gauged from an analysis of company filings.

Quince Therapeutics's Income Statement (based on Industry Averages)

Quince Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Quince Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
May 31, 2018	36	99%	$86 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Quince Therapeutics is developing and marketing. Quince Therapeutics doesn't have any recent trademark applications, indicating Quince Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
QUINCE Pharmaceutical, medicinal and biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders	04/27/2022
CORTEXYME Pharmaceutical preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders; biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders; medicinal preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders	12/11/2015

See all trademarks and details in the Full Report.

Market Share of Quince Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Quince Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LCP HAMPTON BEACH HOSPITALITY	Plymouth, MA	100
BOOZ ALLEN HAMILTON	Mclean, VA	16
ACCENTURE	Chicago, IL	14
MCKINSEY	New York, NY	12
DELAWARE NORTH COMPANIES	Buffalo, NY	6
ATLAS TECHNOLOGY SOLUTIONS	Chicago, IL	5
MAXIMUS SERVICES	Mclean, VA	5
WILLIS TOWERS WATSON US	Arlington, VA	4
KBR HOLDINGS	Houston, TX	3

Nearby Competitors

These companies are similar in business line and location to Quince Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
LYRA HEALTH	Burlingame, CA	100
CONFLUENT	Mountain View, CA	88
LIVONGO HEALTH	Mountain View, CA	40
RESOURCE INNOVATIONS	Half Moon Bay, CA	29
SPHERE INSTITUTE	Burlingame, CA	27
ASE U.S.	Sunnyvle, CA	11

Other Companies at 601 Gateway Blvd, South San Francisco CA

Company	Headquarters	Revenue ($ MM)
AXIA VEGETABLE SEEDS GROUP	South San Francisco, CA	100
RACE TECHNOLOGIES	S San Fran, CA	64
AKERO THERAPEUTICS	South San Francisco, CA	41
SIMPSON GARRITY INNES & JACUZZI APC	South San Francisco, CA	8
OUTPOST GAMES	South San Francisco, CA	1

Future Competition: Quince Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Quince Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)